Option Care Health (NASDAQ:OPCH) Issues FY 2025 Earnings Guidance

Option Care Health (NASDAQ:OPCH) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 1.590-1.690 for the period, compared to the consensus estimate of 1.240. The company issued revenue guidance of $5.2 billion-$5.4 billion, compared to the consensus revenue estimate of $5.2 billion. Option Care Health also updated its FY 2024 guidance to 1.550-1.590 EPS.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on OPCH shares. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their target price for the company from $26.00 to $33.00 in a report on Monday. Truist Financial lowered their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Barrington Research increased their target price on Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a research note on Tuesday. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Finally, Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and dropped their price target for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $29.86.

Option Care Health Trading Up 3.6 %

NASDAQ:OPCH opened at $28.72 on Wednesday. The company has a market cap of $4.89 billion, a PE ratio of 24.13, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company has a 50 day simple moving average of $23.33 and a two-hundred day simple moving average of $27.70. Option Care Health has a 12 month low of $21.39 and a 12 month high of $34.63.

Insider Activity at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the purchase, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.64% of the stock is owned by company insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.